Polyautoimmunity in a Greek cohort of multiple sclerosis

Acta Neurologica Scandinavica

Volumn 131, Issue 4, 2015, Pages 225-230

  Deretzi, G ^a   Kountouras, J ^b   Polyzos, S A ^b   Koutlas, E ^a   Pelidou, S H ^c   Xeromerisiou, G ^a   Zavos, C ^b   Tsiptsios, I ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Autoimmune tautology; Multiple autoimmune syndrome; Multiple sclerosis; Polyautoimmunity

Indexed keywords

ADDISON DISEASE; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; BEHCET DISEASE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GRAVES DISEASE; GREECE; HASHIMOTO DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSULIN DEPENDENT DIABETES MELLITUS; IRITIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE AUTOIMMUNE SYNDROME; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROLOGIST; PATHOGENESIS; PEMPHIGUS; POLYAUTOIMMUNITY; PSORIASIS; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SEX RATIO; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; VITILIGO; AGED; AUTOIMMUNE DISEASES; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; PREVALENCE;

ADULT; AGED; AUTOIMMUNE DISEASES; AUTOIMMUNITY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 84925106452     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12308     Document Type: Article

References (35)

1. Anaya JM. The diagnosis and clinical significance of polyautoimmunity. Autoimmun Rev 2014;13:423-6.
2. Marrie RA, Horwitz RI. Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol 2010;9:820-8.
3. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009;33:197-207.
4. Ramagopalan SV, Dyment DA, Valdar W et al. Autoimmune disease in families with multiple sclerosis: a population based study. Lancet Neurol 2007;6:604-10.
5. Deretzi G, Kountouras J, Koutlas E et al. Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece. Mult Scler 2010;16:1091-101.
6. Eaton WW, Pedersen MG, Attladottir HO et al. The prevalence of 30 ICD-10 autoimmune diseases in Denmark. Immunol Res 2010;47:228-31.
7. Sardu C, Cocco E, Mereu A et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS ONE 2012;7:e32487.
8. Anaya JM, Castiblanco J, Rojas-Villarraga A et al. The Multiple Autoimmune Syndromes. A Clue for the Autoimmune Tautology. Clin Rev Allergy Immunol 2012;43:256-64.
9. Huynh JL, Casaccia P. Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment. Lancet Neurol 2013;12:195-206.
10. Mechelli R, Umeton R, Policano C et al. A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis. PLoS ONE 2013;16:e63300.
11. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005;129:827-36.
12. Fellner A, Dano M, Regev K et al. Multiple sclerosis is associated with psoriasis. A case-control study. J Neurol Sci 2014;338:226-8.
13. Deretzi G, Kountouras J, Zavos C et al. Multiple sclerosis, idiopathic dilated cardiomyopathy, and insulin-dependent diabetes mellitus: a common mechanism of irregular immune regulation. Neurologist 2011;17:172-5.
14. Fanouriakis A, Mastorodemos V, Pamfil C et al. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history. Semin Arthritis Rheum 2014;43:751-8. Nov 13.pii: S0049-0172(13)00250-3. doi:10.1016/j.semarthrit.2013.11.007. (Epub ahead of print).
15. Attout H, Toussirot E, Auge B et al. Rheumatoid arthritis and multiple sclerosis in the same patient: two case reports. Rev Rhum Engl Ed 1999;66:169-72.
16. Tan FU, Tellioglu S, Aydin G et al. Ankylosing spondylitis and multiple sclerosis in an HLA-B27 negative patient. Acta Neurol Belg 2004;104:169-72.
17. Pelidou SH, Tsifetaki N, Giannopoulos S et al. Multiple sclerosis associated with systemic sclerosis. Rheumatol Int 2007;27:771-3.
18. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
19. Magyari M, Koch-Henriksen N, Pfleger CC et al. Gender and autoimmune comorbidity in multiple sclerosis. Mult Scler 2014;34:712-16.
20. Kountouras J, Deretzi G, Gavalas E et al. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders. Med Hypotheses 2014;82:368-73.
21. Gavalas E, Kountouras J, Deretzi G et al. Helicobacter pylori and multiple sclerosis. J Neuroimmunol 2007;188:187-9.
22. Deretzi G, Kountouras J, Grigoriadis N et al. From the "little brain" gastrointestinal infection to the "big brain" neuroinflammation a proposed fast axonal transport pathway involved in multiple sclerosis. Med Hypotheses 2009;73:781-7.
23. Deretzi G, Kountouras J, Polyzos SA et al. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases. Curr Mol Med 2011;11:696-707.
24. Kountouras J, Zavos C, Gavalas E et al. Helicobacter pylori may be a common denominator associated with systemic and multiple sclerosis. Joint Bone Spine 2011;78:222-3.
25. Deretzi G, Kountouras J, Gavalas E et al. Multiple sclerosis and seizures: possible role of Helicobacter pylori. Eur J Neurol 2011;18:e116.
26. Kountouras J, Deretzi G, Gavalas E et al. Aquaporin 4, Helicobacter pylori and potential implications for neuromyelitis optica. J Neuroimmunol 2013;263:162-3.
27. Sellner J, Kraus J, Awad A et al. The increasing incidence and prevalence of female multiple sclerosis-a critical analysis of potential environmental factors. Autoimmun Rev 2011;10:495-502.
28. Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: autoimmune old and new players. Eur J Endocrinol 2014;170:R241-52.
29. Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity 2005;38:247-55.
30. Jones SA, Sutton CE, Cua D, Mills KH. Therapeutic potential of targeting IL-17. Nat Immunol 2012;13:1022-5.
31. Ponomarev ED, Dittel BN. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J Immunol 2005;174:4678.
32. Krueger GG, Langley RG, Leonardi C et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007;356:580-92.
33. Segal BM, Constantinescu CS, Raychaudhuri A et al. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008;7:796-804.
34. Ghoreschi K, Brück J, Kellerer C et al. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med 2011;208:2291-303.
35. Claussen MC, Korn T. Immune mechanisms of new therapeutic strategies in MS: teriflunomide. Clin Immunol 2012;142:49-56.